关注
C Hur
C Hur
Professor of Medicine and Epidemiology, Columbia University
在 columbia.edu 的电子邮件经过验证
标题
引用次数
年份
1132 THE COST-EFFECTIVENESS OF SCREENING AND SURVEILLANCE OF PRECURSOR GASTRIC LESIONS IN INDIVIDUALS WITH A FAMILY HISTORY OF GASTRIC CANCER
M Laszkowska, AI Hahn, S King, F Lim, JS Ferris, M Prest, A Agyekum, ...
Gastroenterology 164 (6), S-234, 2023
2023
1231 Racial and Ethnic Differences in Mortality in Gastric Cancer and Esophageal Adenocarcinoma in the United States
M Laszkowska, A Tramontano, J Kim, MC Camargo, A Neugut, J Abrams, ...
Official journal of the American College of Gastroenterology| ACG 114, S686-S687, 2019
2019
131-Does the Retroview Colonoscope Enhance Polyp Detection Compared to a Standard Colonoscope?
M Lee, M Klebanoff, C Hur, NS Nishioka, PB Kelsey, B Casey
Gastroenterology 154 (6), S-35, 2018
2018
235 Accuracy of Post-Hoc High-Resolution Microendoscopy for Diagnosis of Esophageal Squamous Cell Neoplasia
MC Tan, T Quang, KK Patel, RA Schwarz, C Hur, F Zhang, Y Xinying, ...
Gastroenterology 150 (4), S55, 2016
2016
263 UNIVERSAL SCREENING STRATEGIES FOR OPTIMAL IDENTIFICATION OF LYNCH SYNDROME IN COLORECTAL CANCER PATIENTS AND AT-RISK RELATIVES
MA Ingram, SD Rustgi, JT Gabre, J Soddano, C Hur, F Kastrinos
Gastroenterology 164 (6), S-45, 2023
2023
318 The Cost-Effectiveness of Radiofrequency Ablation for Barrett's Esophagus
C Hur, SE Choi, JH Rubenstein, CY Kong, D Provenzale, NS Nishioka, ...
Gastroenterology 5 (142), S-73, 2012
22012
519–The Age to Stop Endoscopic Surveillance of Barrett's Esophagus: A Cost-Effectiveness Analysis
AH Omidvari, M Lee, SK Naber, WD Hazelton, CY Kong, E Richmond, ...
Gastroenterology 156 (6), S-103-S-104, 2019
2019
520–Overuse of Surveillance Endoscopy for Barrett's Esophagus in Individuals with Limited Life Expectancy
JH Rubenstein, M Noureldin, A Tavakkoli, C Hur, JM Inadomi, ...
Gastroenterology 156 (6), S-104, 2019
2019
538 POPULATION SCREENING FOR LYNCH SYNDROME: INSIGHTS FROM THE ALL OF US RESEARCH PROGRAM
J Park, H Karnati, SD Rustgi, C Hur, XF Kong, F Kastrinos
Gastroenterology 166 (5), S-121-S-122, 2024
2024
694: ENDOSCOPIC SCREENING FOR ESOPHAGEAL ADENOCARCINOMA IN VARIED POPULATIONS: A COMPARATIVE COST-EFFECTIVENESS ANALYSIS
JH Rubenstein, AH Omidvari, B Lauren, WD Hazelton, F Lim, SX Tan, ...
Gastroenterology 162 (7), S-173-S-174, 2022
2022
786 Effectiveness and Cost-Effectiveness of Once-Only Screening for Colorectal Cancer With Colonoscopy or Computed Tomographic Colonography
AB Knudsen, C Hur, KM Kuntz, U Haug, GS Gazelle
Gastroenterology 5 (142), S-141-S-142, 2012
2012
827–Optimal Timing of Total Gastrectomy to Prevent Hereditary Diffuse Gastric Cancer in Individuals with Pathogenic Cdh1 Mutations
M Laszkowska, ER Silver, B Schrope, F Kastrinos, TC Wang, C Hur
Gastroenterology 156 (6), S-178, 2019
2019
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E2 in patients with Barrett's esophagus
GW Falk, NS Buttar, NR Foster, KLA Ziegler, CJ DeMars, Y Romero, ...
Gastroenterology 143 (4), 917-926. e1, 2012
652012
A decision analysis of competing strategies for prevention of post-operative recurrence in Crohn's disease
AN Ananthakrishnan, P Juillerat, C Hur, JR Korzenik
Gastroenterology 5 (140), S-779, 2011
12011
A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancer
AM Praiss, Y Huang, CMS Clair, AI Tergas, A Melamed, F Khoury-Collado, ...
Gynecologic Oncology 157 (2), 329-334, 2020
72020
A quantitative exploration of gastrointestinal bleeding in intensive care unit patients
PC Eschenfeldt, C Hur
Plos one 14 (2), e0212040, 2019
12019
A summary of the 2020 gastric cancer summit at Stanford University
RJ Huang, H Koh, JH Hwang, CC Abnet, F Alarid-Escudero, MR Amieva, ...
Gastroenterology 159 (4), 1221-1226, 2020
322020
AB006. S006. Variation in longterm oncologic outcomes by types of cancer center accreditation: an analysis of a SEER-Medicare population with pancreatic cancer
ZV Fong, D Chang, CF Castillo, C Ferrone, G Jin, A Tramontano, C Hur, ...
Annals of Pancreatic Cancer 1 (4), 2018
2018
Abstract CN06-03: Randomized double-blinded phase II trial of esomeprazole versus esomeprazole+ two doses of aspirin in Barrett's esophagus patients
GW Falk, S Sontag, M Cruz-Correa, D Weinberg, A Chak, C Hur, ...
Cancer Prevention Research 4 (10_Supplement), CN06-03-CN06-03, 2011
2011
Abstract LB-305: Randomized, double-blind, placebo-controlled immunoprevention trial with MUC1 vaccine in patients with newly diagnosed advanced adenomas
RE Schoen, LA Boardman, M Cruz-Correa, A Bansal, PL Beatty, ...
Cancer Research 78 (13_Supplement), LB-305-LB-305, 2018
12018
系统目前无法执行此操作,请稍后再试。
文章 1–20